Terapet SA

Terapet SA was incorporated in Geneva, Switzerland in December 2019, a CERN MedTech spin-off. The founders are Dr. Christina Vallgren (PhD in Applied Physics, MSc in Nuclear Physics and MBA), Dr. Marcus Palm (PhD in Applied Physics, MSc in Engineering Physics and Electronics) and Prof. Raymond Miralbell (Radiation Oncologist 40+ years). Terapet’s mission is to develop an innovative platform technology with integrated solutions for imaging in nuclear medicine, bringing proton therapy, nuclear imaging and precision medicine to the next level. Terapet envisions that its Qualyscan™ and Claryscan™ will enable QUALITY and CLARITY in every patient’s diagnostic and treatment, making them the first choice for radiotherapy and precision medicine in the near future.